Isometheptene
| Isometheptene | |
|---|---|
| Salts [] | |
|---|---|
| Isometheptene hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 141.25 g/mol [1] |
| Predicted LogP | 2.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H19N |
| IUPAC name | N,6-dimethylhept-5-en-2-amine |
| SMILES | CC(CCC=C(C)C)NC |
| InChI | InChI=1S/C9H19N/c1-8(2)6-5-7-9(3)10-4/h6,9-10H,5,7H2,1-4H3 |
| InChIKey | XVQUOJBERHHONY-UHFFFAOYSA-N |
| CAS number | 503-01-5 |
| UNII | Y7L24THH6T |
| PubChem CID | 22297 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral |
Isometheptene (also known as Octanil, Isonyl, Octin, 6-Methylamino-2-methylheptene, 5-Hepten-2-amine, N,6-dimethyl-, Isometepteno, Isometheptenum, Methyloctenylamine, methyl(6-methylhept-5-en-2-yl)amine or N,6-Dimethyl-5-hepten-2-amine) is a sympathomimetic substance of the amine class.
Chemistry
Salts []
Stereochemistry []
Isometheptene is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Isometheptene matches Lipinski's rule of five.Pharmacology
ATC Classification
- alimentary tract and metabolism (A)
- drugs for functional gastrointestinal disorders (A03)
- drugs for functional gastrointestinal disorders (A03A)
- other drugs for functional gastrointestinal disorders (A03AX)
- isometheptene (A03AX10)
Mechanism of action []
Isometheptene's vasoconstricting properties arise through activation of the sympathetic nervous system via epinephrine and norepinephrine (or their molecular analogues as is the case with this drug). These compounds elicites smooth muscle activation leading to vasoconstriction. These compounds interact with cell surface adrenergic receptors. Such stimuli result in a signal transduction cascade that leads to increased intracellular calcium from the sarcoplasmic reticulum through IP3 mediated calcium release, as well as enhanced calcium entry across the sarcolemma through calcium channels. The rise in intracellular calcium complexes with calmodulin, which in turn activates myosin light chain kinase. This enzyme is responsible for phosphorylating the light chain of myosin to stimulate cross bridge cycling. Once elevated, the intracellular calcium concentration is returned to its basal level through a variety of protein pumps and calcium exchangers located on the plasma membrane and sarcoplasmic reticulum. This reduction in calcium removes the stimulus necessary for contraction allowing for a return to baseline. The drug can also cause vesicular displacement of noradrenaline from the neuron into the synapse with a similar effect as tyramine. [1]
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 22297, Isometheptene. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/22297
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Isometheptene. UNII: Y7L24THH6T. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Y7L24THH6T
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 03:07:31 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 03:07:27 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 03:07:27 |
| gsrs | ok | 2026-11-20 03:07:29 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015651) | 2026-11-20 03:07:27 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 03:07:32 |
| pubchem | ok | 2026-11-20 03:07:26 |
| missing (no r/tripreports posts mention it) | 2026-11-20 03:07:27 | |
| sider | missing (not in SIDER) | 2026-11-20 03:07:27 |
| structure | ok | 2026-11-20 03:07:27 |
| wikipedia | ok | 2026-11-20 03:07:27 |